Private Label: o potencial impacto no mercado de medicamentos no Brasil
The objective of this article is to discuss how the release of private labels would change the dynamics of the industry with the eventual concentration of the retailer’s power in the medicines market. To this end, important theoretical aspects will be raised, based, for example, on Michael Porter’s theory (Five Competitive Forces and Value Chain). As a
Ronaldo Raemy Rangel +2 more
openalex +4 more sources
O Mercado de medicamentos no Brasil e no mundo
Este trabalho é parte de um estudo maior sobre as parcerias para o desenvolvimento produtivo (PDPs), que tem como uma de suas metas principais entender como precificar as tecnologias que as PDPs transferem para os laboratórios públicos.
Queiroz Sérgio R. R. de
openalex +2 more sources
PROSPECÇÃO DE MERCADO VISANDO P&D PARA MEDICAMENTOS VETERINÁRIOS PARA BOVINOCULTURA NO BRASIL
Helio De Sena Gouvea Omote +1 more
openalex +2 more sources
Consumption of drugs for Alzheimer's disease on the Brazilian private market. [PDF]
Freitas EL +4 more
europepmc +1 more source
Prices paid for primary health care medicines by Brazilian municipalities. [PDF]
Silva WROD +5 more
europepmc +1 more source
A política de medicamentos genéricos e o mercado farmacêutico na Argentina e no Brasil
Evangelina Martich
openalex +1 more source
Drugs incorporated into the Brazilian Unified Health System: document analysis of methodological decisions in budget impact analyses between 2012 and 2024. [PDF]
Curado DDSP, Silva END.
europepmc +1 more source
Small-Vessel Coronary Disease and Drug-Coated Balloons: Time to Reconsider Our Strategy? [PDF]
Prado GFA, Ribeiro HB.
europepmc +1 more source
[Extension of the term of validity of pharmaceutical patents by lawsuits: effects on centralized procurement and the private market]. [PDF]
Paranhos J +4 more
europepmc +1 more source

